Novozymes CEO: "We haven't met our targets in six years"
![Photo: NOVOZYMES](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13318727.ece/ALTERNATES/schema-16_9/doc7hqcxr0r5g94wdn7gzm.jpg)
Danish enzyme producer Novozymes' new growth strategy, "Unlocking Growth – Powered by Biotech", stretching to the end of 2025, will pull the company out of an unfortunate trend, says Chief Executive Ester Baiget during the company's virtual capital markets day on Tuesday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novozymes to still run on bioethanol
For subscribers
Bioenergy sales grow markedly at Novozymes
For subscribers